Log In
BCIQ
Print this Print this
 

LAS41008

  Manage Alerts
Collapse Summary General Information
Company Almirall S.A.
DescriptionDimethyl fumarate targeting nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPsoriasis
Indication DetailsTreat moderate to severe chronic plaque psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today